Phase I Trial of the Human Double Minute 2 Inhibitor MK-8242 in Patients With Advanced Solid Tumors. (Q33439682)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase I Trial of the Human Double Minute 2 Inhibitor MK-8242 in Patients With Advanced Solid Tumors. |
scientific article |
Statements
Phase I Trial of the Human Double Minute 2 Inhibitor MK-8242 in Patients With Advanced Solid Tumors (English)
Andrew J Wagner
Neeta Somaiah
Heather Hirsch
Craig Fancourt
Amy O Johnson-Levonas
Raymond Lam
Amy K Meister
Giuseppe Russo
Clayton D Knox
Shelonitda Rose
27 February 2017